Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emergent HIV drug resistance in non-inferiority trials.
Ripamonti D, Zazzi M. Ripamonti D, et al. Among authors: zazzi m. Lancet HIV. 2023 Oct;10(10):e632-e634. doi: 10.1016/S2352-3018(23)00203-5. Epub 2023 Sep 12. Lancet HIV. 2023. PMID: 37714175 No abstract available.
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study.
Gagliardini R, Ciccullo A, Borghetti A, Maggiolo F, Bartolozzi D, Borghi V, Pecorari M, Di Biagio A, Callegaro AP, Bruzzone B, Saladini F, Paolucci S, Maserati R, Zazzi M, Di Giambenedetto S, De Luca A; ARCA Study Group. Gagliardini R, et al. Among authors: zazzi m. Open Forum Infect Dis. 2018 May 15;5(6):ofy113. doi: 10.1093/ofid/ofy113. eCollection 2018 Jun. Open Forum Infect Dis. 2018. PMID: 29977967 Free PMC article.
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".
Panza F, Saladini F, Bartolini N, Gianmarino F, Montagnani F, Spagnuolo V, Tumbarello M, Santoro MM, Castagna A, Zazzi M, Fabbiani M. Panza F, et al. Among authors: zazzi m. New Microbiol. 2024 May;47(1):116-122. New Microbiol. 2024. PMID: 38700893 Free article.
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.
Borghetti A, Ciccullo A, Lombardi F, Giannarelli D, Passerotto RA, Lamanna F, Carcagnì A, Farinacci D, Dusina A, Baldin G, Zazzi M, Di Giambenedetto S. Borghetti A, et al. Among authors: zazzi m. Open Forum Infect Dis. 2024 Apr 10;11(5):ofae198. doi: 10.1093/ofid/ofae198. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38680613 Free PMC article.
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project.
Hedberg P, Parczewski M, Serwin K, Marchetti G, Bai F, Ole Jensen BE, Pereira JPV, Drobniewski F, Reschreiter H, Naumovas D, Ceccherini-Silberstein F, Rubio Quintanares GH, Mwau M, Toscano C, König F, Pfeifer N, Zazzi M, Fanti I, Incardona F, Cozzi-Lepri A, Sönnerborg A, Nauclér P. Hedberg P, et al. Among authors: zazzi m. Lancet Reg Health Eur. 2024 Feb 2;38:100855. doi: 10.1016/j.lanepe.2024.100855. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38476753 Free PMC article.
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors.
Clemente T, Galli L, Lolatto R, Gagliardini R, Lagi F, Ferrara M, Cattelan AM, Focà E, Di Biagio A, Cervo A, Calza L, Maggiolo F, Marchetti G, Cenderello G, Rusconi S, Zazzi M, Santoro MM, Spagnuolo V, Castagna A; PRESTIGIO Study Group. Clemente T, et al. Among authors: zazzi m. BMJ Open. 2024 Feb 10;14(2):e080606. doi: 10.1136/bmjopen-2023-080606. BMJ Open. 2024. PMID: 38341206 Free PMC article.
Lower aids-related hospitalizations in women living with HIV multidrug resistance.
Papaioannu Borjesson R, Galli L, Lolatto R, Menzaghi B, Feasi M, Gulminetti R, Fornabaio C, Cattelan AM, Bonora S, Lagi F, Zazzi M, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Papaioannu Borjesson R, et al. Among authors: zazzi m. AIDS. 2024 Mar 1;38(3):435-438. doi: 10.1097/QAD.0000000000003781. Epub 2024 Feb 1. AIDS. 2024. PMID: 38300163 No abstract available.
314 results